Medicine. A comeback for gene therapy
- PMID: 19892968
- DOI: 10.1126/science.1181937
Medicine. A comeback for gene therapy
Comment on
-
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242. Science. 2009. PMID: 19892975
Similar articles
-
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242. Science. 2009. PMID: 19892975
-
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.N Engl J Med. 2017 Oct 26;377(17):1630-1638. doi: 10.1056/NEJMoa1700554. Epub 2017 Oct 4. N Engl J Med. 2017. PMID: 28976817 Free PMC article. Clinical Trial.
-
[Gene therapy starts to tackle CNS disease].Rinsho Shinkeigaku. 2010 Nov;50(11):842. doi: 10.5692/clinicalneurol.50.842. Rinsho Shinkeigaku. 2010. PMID: 21921466 Japanese. No abstract available.
-
X-linked adrenoleukodystrophy.Ann N Y Acad Sci. 1996 Dec 27;804:461-76. doi: 10.1111/j.1749-6632.1996.tb18637.x. Ann N Y Acad Sci. 1996. PMID: 8993565 Review. No abstract available.
-
X-linked adrenoleukodystrophy: pathogenesis and treatment.Curr Neurol Neurosci Rep. 2014 Oct;14(10):486. doi: 10.1007/s11910-014-0486-0. Curr Neurol Neurosci Rep. 2014. PMID: 25115486 Review.
Cited by
-
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders.Open Life Sci. 2021 May 3;16(1):431-441. doi: 10.1515/biol-2021-0033. eCollection 2021. Open Life Sci. 2021. PMID: 33987480 Free PMC article. Review.
-
Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye.Pharm Res. 2018 Dec 27;36(2):29. doi: 10.1007/s11095-018-2554-7. Pharm Res. 2018. PMID: 30591984 Free PMC article. Review.
-
Effects of lentivirus-mediated endostatin on endothelial progenitor cells.Oncotarget. 2017 Oct 10;8(55):94431-94439. doi: 10.18632/oncotarget.21770. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212239 Free PMC article.
-
NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.Curr Med Chem. 2018 Jan 30;25(3):404-432. doi: 10.2174/0929867324666170718101946. Curr Med Chem. 2018. PMID: 28721829 Free PMC article. Review.
-
Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.EMBO Mol Med. 2017 Jul;9(7):918-932. doi: 10.15252/emmm.201607354. EMBO Mol Med. 2017. PMID: 28526679 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
